Background: Inherited susceptibility genes have been associated with histopathologic characteristics of tumors. Objective: We sought to identify associations between histology of melanomas and CDKN2A genotype. Methods: This was a case-control study design comparing 28 histopathologic tumor features among individuals with sporadic melanomas (N = 81) and cases from melanoma families with (N = 123) and without (N = 120) CDKN2A germline mutations. Results: Compared with CDKN2A− cases, mutation carriers tended to have histologic features of superficial spreading melanoma subtype including higher pigmentation (Ptrend = .02) and increased pagetoid scatter (Ptrend = .07) after adjusting for age at diagnosis, sex, and American Joint Committee on Can...
BACKGROUND: : Inherited mutations in the CDKN2A tumor suppressor gene, which encodes the p16(INK4a) ...
Background Patients who develop cutaneous melanoma are at increased risk of developing a second prim...
BACKGROUND: Germline mutations in CDKN2A have been associated with increased risk of melanoma and to...
Background: Inherited susceptibility genes have been associated with histopathologic characteristics...
Background: Inherited susceptibility genes have been associated with histopathologic characteristics...
Background: About 10% of cutaneous malignant melanomas (CMM) occur in individuals with a family hist...
Germline mutations on the CDKN2A gene, the most important known genetic factors associated with cuta...
Germline mutations on the CDKN2A gene, the most important known genetic factors associated with cuta...
Purpose: Carriers of CDKN2A mutations have high risks of melanoma and certain other cancers. In this...
Primary cutaneous malignant melanomas (CMMs) from 26 individuals belonging to nine families with an ...
Background: Cutaneous malignant melanoma (CMM) is an increasingly common cancer in fair-skinned peop...
CDKN2A is the most common, most penetrant gene whom germline mutations predisposing to cutaneous fam...
BACKGROUND: Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associa...
Non-invasive diagnostic tools are effective in the histomorphological study of melanocytic lesions. ...
Non-invasive diagnostic tools are effective in the histomorphological study of melanocytic lesions. ...
BACKGROUND: : Inherited mutations in the CDKN2A tumor suppressor gene, which encodes the p16(INK4a) ...
Background Patients who develop cutaneous melanoma are at increased risk of developing a second prim...
BACKGROUND: Germline mutations in CDKN2A have been associated with increased risk of melanoma and to...
Background: Inherited susceptibility genes have been associated with histopathologic characteristics...
Background: Inherited susceptibility genes have been associated with histopathologic characteristics...
Background: About 10% of cutaneous malignant melanomas (CMM) occur in individuals with a family hist...
Germline mutations on the CDKN2A gene, the most important known genetic factors associated with cuta...
Germline mutations on the CDKN2A gene, the most important known genetic factors associated with cuta...
Purpose: Carriers of CDKN2A mutations have high risks of melanoma and certain other cancers. In this...
Primary cutaneous malignant melanomas (CMMs) from 26 individuals belonging to nine families with an ...
Background: Cutaneous malignant melanoma (CMM) is an increasingly common cancer in fair-skinned peop...
CDKN2A is the most common, most penetrant gene whom germline mutations predisposing to cutaneous fam...
BACKGROUND: Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associa...
Non-invasive diagnostic tools are effective in the histomorphological study of melanocytic lesions. ...
Non-invasive diagnostic tools are effective in the histomorphological study of melanocytic lesions. ...
BACKGROUND: : Inherited mutations in the CDKN2A tumor suppressor gene, which encodes the p16(INK4a) ...
Background Patients who develop cutaneous melanoma are at increased risk of developing a second prim...
BACKGROUND: Germline mutations in CDKN2A have been associated with increased risk of melanoma and to...